| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |